Insider Trading February 24, 2026

Tredegar 10% Owner John Gottwald Sells 5,484 Shares, Fetching About $48,278

Two transactions on Feb. 20 and Feb. 23 reduced holdings held in a CLAT trust as the stock trades near its 52-week peak

By Marcus Reed TG
Tredegar 10% Owner John Gottwald Sells 5,484 Shares, Fetching About $48,278
TG

John D. Gottwald, listed as a 10% owner of Tredegar Corp (NYSE: TG), completed two open-market sales totaling 5,484 shares on Feb. 20 and Feb. 23, 2026, for roughly $48,278. The trades occurred while Tredegar's stock traded at $8.82, near its 52-week high of $9.43 and up 22% year-to-date. Post-sale holdings and related ownership stakes are detailed in a Form 4 filed with the Securities and Exchange Commission.

Key Points

  • Insider sales totaled 5,484 shares on Feb. 20 and Feb. 23, 2026, for approximately $48,278.
  • Post-sale trust holdings: 582,945 shares after Feb. 20 and 578,484 shares after Feb. 23 reported for the Residual 10- Year CLAT UA FDGJR Living Trust.
  • Analyst snapshot notes a 135x P/E and no dividend; stock trading near 52-week high and up 22% YTD.

John D. Gottwald, identified as a ten percent owner of Tredegar Corp (NYSE: TG), reported two separate share dispositions in a Form 4 filing with the Securities and Exchange Commission. The filings show a combined sale of 5,484 shares on February 20 and February 23, 2026, for a total of approximately $48,278.

The first transaction, executed on February 20, involved the sale of 1,023 shares at transaction prices ranging from $8.80 to $8.84 per share. After that sale, Gottwald is reported to directly hold 582,945 Tredegar shares in his capacity as co-trustee of the Residual 10- Year CLAT UA FDGJR Living Trust.

The second, larger sale took place on February 23 and consisted of 4,461 shares sold at prices falling between $8.80 and $8.85 per share. Following the February 23 transaction, the filing shows Gottwald directly holds 578,484 Tredegar shares as co-trustee of the Residual 10- Year CLAT UA FDGJR Living Trust.

The sales occurred while Tredegar's shares were trading at $8.82, a level noted as near the 52-week high of $9.43, with shares up 22% year-to-date. The Form 4 filing supplies further detail on Gottwald's broader ownership positions in Tredegar.

In addition to the holdings reported as co-trustee of the Residual 10- Year CLAT UA FDGJR Living Trust, Gottwald directly owns 1,917,639 shares of Tredegar common stock. The filing also lists indirect and other trust-related holdings: 12,953 shares held by his wife, 90,000 shares held as co-trustee of the John D. Gottwald Family Trust, and 847,470 shares held as co-trustee for family.

Independent analysis noted in the filing documents indicates Tredegar trades at a high price-to-earnings ratio of 135x and does not pay a dividend to shareholders. Those two metrics were identified as part of the analytical snapshot provided to subscribers.

The Form 4-based disclosure provides a snapshot of insider activity and current ownership concentration tied to a significant shareholder but does not include commentary on intent or future transactions.


Clear summary

John D. Gottwald sold 5,484 Tredegar shares across two trades on Feb. 20 and Feb. 23, 2026, netting about $48,278 while the stock traded near its 52-week high; the filing details both direct and indirect holdings and notes the company’s 135x P/E and lack of dividend.

Key points

  • Insider sales totaled 5,484 shares on Feb. 20 and Feb. 23, 2026, for roughly $48,278.
  • Gottwald’s post-sale holdings as co-trustee of the Residual 10- Year CLAT UA FDGJR Living Trust were 582,945 shares after Feb. 20 and 578,484 shares after Feb. 23.
  • Analytical snapshot included: P/E of 135x and no dividend; the market context shows the stock trading near a 52-week high and up 22% year-to-date.

Risks and uncertainties

  • Insider transactions do not disclose intent - investors may not infer future company performance from these sales alone. This affects equity market participants assessing insider signals.
  • The company’s high P/E ratio of 135x may reflect elevated valuation metrics that some investors view as a risk; this influences valuation-sensitive market participants.
  • The absence of a dividend removes income-oriented support for the stock, which could matter to dividend-focused investors and certain institutional buyers.

Risks

  • Insider sales provide no explicit statement of intent; market participants cannot infer future company performance from these transactions alone.
  • A high P/E ratio (135x) may indicate elevated valuation risk for investors sensitive to earnings multiples.
  • Lack of dividend removes income support for dividend-focused investors, which may affect certain buyer demand.

More from Insider Trading

Peapack-Gladstone Director Sells Small Stake as Company Moves to Redeem Debt and Grant Executive RSUs Mar 23, 2026 Progressive Accounting Chief Disposes $55K in Stock as Shares Trade Near Yearly Low Mar 23, 2026 Old Second Bancorp Vice Chairman Disposes $429K in Shares; Ownership Stakes and Recent Results Also Detailed Mar 23, 2026 Vicor Chairman Disposes $7.9 Million in Stock; Transaction Executed Under 10b5-1 Plan Mar 23, 2026 Nutex Health President Buys $23,706 in Stock as Q4 Revenue Slumps 41.1% Mar 23, 2026